Tumor Infiltrating Lymphocytes and Response To Neoadjuvant Chemotherapy in Invasive Breast Cancer

被引：0
|
作者：
Fineberg, Susan [1 ]
McLemore, Lauren [1 ]
机构：
[1] Montefiore Med Ctr, Bronx, NY 10467 USA
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
167
引用
收藏
页码：45A / 45A
页数：1
相关论文
共 50 条
  • [41] An Immunoscore Using PD-L1, CD68, and Tumor-infiltrating Lymphocytes (TILs) to Predict Response to Neoadjuvant Chemotherapy in Invasive Breast Cancer
    McLemore, Lauren E.
    Janakiram, Murali
    Albanese, Joseph
    Shapiro, Nella
    Lo, Yungtai
    Zang, Xingxing
    Fineberg, Susan
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2018, 26 (09) : 611 - 619
  • [42] Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden
    Asano, Yuka
    Kashiwagi, Shinichiro
    Goto, Wataru
    Takada, Koji
    Takahashi, Katsuyuki
    Hatano, Takaharu
    Noda, Satoru
    Takashima, Tsutomu
    Onoda, Naoyoshi
    Tomita, Shuhei
    Motomura, Hisashi
    Ohsawa, Masahiko
    Hirakawa, Kosei
    Ohira, Masaichi
    [J]. BMC CANCER, 2017, 17
  • [43] Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden
    Yuka Asano
    Shinichiro Kashiwagi
    Wataru Goto
    Koji Takada
    Katsuyuki Takahashi
    Takaharu Hatano
    Satoru Noda
    Tsutomu Takashima
    Naoyoshi Onoda
    Shuhei Tomita
    Hisashi Motomura
    Masahiko Ohsawa
    Kosei Hirakawa
    Masaichi Ohira
    [J]. BMC Cancer, 17
  • [44] Prediction of treatment response to neoadjuvant chemotherapy in breast cancer by subtype using tumor-infiltrating lymphocytes: Study of a large Mexican cohort
    Campos Gomez, S.
    Cabanas Chavez, N.
    Hernandez Alvarez, J.
    Campos Gomez, K.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [45] Predictive value of tumor-infiltrating lymphocytes for pathological response to neoadjuvant chemotherapy in breast cancer patients with axillary lymph node metastasis
    Yokotani, Tomoyo
    Ikeda, Noaya
    Hirao, Tomoko
    Tanaka, Yukimi
    Morita, Kohei
    Fujii, Tomomi
    Ohbayashi, Chiho
    Nakamura, Takashi
    Kobayashi, Toyoki
    Sho, Masayuki
    [J]. SURGERY TODAY, 2021, 51 (04) : 595 - 604
  • [46] Predictive value of tumor-infiltrating lymphocytes for pathological response to neoadjuvant chemotherapy in breast cancer patients with axillary lymph node metastasis
    Tomoyo Yokotani
    Noaya Ikeda
    Tomoko Hirao
    Yukimi Tanaka
    Kohei Morita
    Tomomi Fujii
    Chiho Ohbayashi
    Takashi Nakamura
    Toyoki Kobayashi
    Masayuki Sho
    [J]. Surgery Today, 2021, 51 : 595 - 604
  • [47] Impact of BRCA Mutation Status on Tumor Infiltrating Lymphocytes (TILs), Response to Treatment, and Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Grandal, Beatriz
    Evrevin, Clemence
    Laas, Enora
    Jardin, Isabelle
    Rozette, Sonia
    Laot, Lucie
    Dumas, Elise
    Coussy, Florence
    Pierga, Jean-Yves
    Brain, Etienne
    Saule, Claire
    Stoppa-Lyonnet, Dominique
    Frank, Sophie
    Senechal, Claire
    Lae, Marick
    De Croze, Diane
    Bataillon, Guillaume
    Guerin, Julien
    Reyal, Fabien
    Hamy, Anne-Sophie
    [J]. CANCERS, 2020, 12 (12) : 1 - 26
  • [48] Prediction of the treatment response to eribulin chemotherapy in breast cancer using tumor-infiltrating lymphocytes
    Kashiwagi, Shinichiro
    Asano, Yuka
    Goto, Wataru
    Kurata, Kento
    Morisaki, Tamami
    Noda, Satoru
    Takashima, Tsutomu
    Onoda, Naoyoshi
    Ohsawa, Masahiko
    Ohira, Masaichi
    Hirakawa, Kosei
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [49] Changes in Tumor-infiltrating Lymphocytes After Neoadjuvant Chemotherapy and Clinical Significance in Triple Negative Breast Cancer
    Lee, Hyun
    Lee, Miseon
    Seo, Jeong-Han
    Gong, Gyungyub
    Lee, Hee Jin
    [J]. ANTICANCER RESEARCH, 2020, 40 (04) : 1883 - 1890
  • [50] Tumor infiltrating lymphocytes (TILs) in breast cancer (BC) patients with progressive disease during neoadjuvant chemotherapy (NAT).
    Raphael, Jacques
    Nofech-Mozes, Sharon
    Paramsothy, Thivaher
    Li, Nim
    Gandhi, Sonal
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345